Interested in advertising your event with Science in the City? Submit your event info to our event calendar!
- This event has passed.
Business Development Basics for Life Science Companies
October 17, 2017, 2017
The business development professional’s purpose is to optimize optionality and long term value at each stage of a company’s life. As a company grows and gains traction, it’s easy to get enticed and overwhelmed by the numerous opportunities that arise. How do you determine the direction that will add the most value to your company? How do you avoid the constant pursuit of “shiny objects”? How do you know when it’s the right time for a strategic partnership?
In this workshop, you’ll learn fundamental business development skills to help you successfully evaluate and manage strategic alliances and other potential growth opportunities.
Topics will include:
- Strategic alliance process management
- Concepts in valuation
- Importance of IP and IP diligence
- Communication and negotiation skills
- Basic components of a contract
This workshop is geared towards business development professionals and management teams of life science startups.
Lesley Stolz | Head, JLABS California, Johnson & Johnson Innovation read bio»
10:00 AM | Registration Opens
10:30 AM | Presentation
11:30 AM | Q&A
12:00 PM | Reception and Networking
1:00 PM | Program Close
$25 | General Public
$15 | Student/Academic
$35 | On site
Room 3340 (Third Floor), 2405 Wesbrook Mall
Pharmaceutical Sciences Building, UBC
Vancouver, BC V6T 1Z3
Lesley Stolz, Ph.D. | Head, JLABS California, Johnson & Johnson Innovation, JLABS
Dr. Stolz has 20 years of business and corporate development experience working for companies that have been both technology platform and therapeutics focused. Prior to joining Johnson & Johnson Innovation, she held executive positions with BioTime, Inc., Sutro Biopharma, Inc., and Sunesis Pharmaceuticals where she was responsible for corporate strategy, fundraising and all aspects of partnering. Earlier in her career, she served as Senior Director, Business Development for Aerovance, Inc. and for GPC Biotech AG in Munich, Germany from 2002 to 2006. She also served in senior management positions at Cell Genesys, Discovery Partners International and Axys Pharmaceuticals. Dr. Stolz received her Ph.D. in chemistry, and conducted postdoctoral research at Harvard Medical School’s Department of Biochemistry and Molecular Pharmacology.